Dow Up0.41% Nasdaq Up1.23%

Pfizer Inc. (PFE)

-NYSE

28.89 Oct 1, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJul 1, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012
Total Revenue 11,883,000   13,500,000   15,068,000   16,105,000  
Cost of Revenue1,853,000  2,652,000  3,172,000  3,403,000  
Gross Profit 10,030,000   10,848,000   11,896,000   12,702,000  
Operating Expenses
Research Development1,440,000  1,800,000  2,136,000  2,160,000  
Selling General and Administrative3,223,000  3,585,000  4,815,000  4,458,000  
Non Recurring176,000  138,000  791,000  316,000  
Others1,125,000  1,234,000  1,236,000  1,261,000  
Total Operating Expenses5,964,000  6,757,000  8,978,000  8,195,000  
Operating Income or Loss 4,066,000   4,091,000   2,918,000   4,507,000  
Income from Continuing Operations
Total Other Income/Expenses Net1,095,000  (170,000)(748,000)(956,000)
Earnings Before Interest And Taxes5,161,000  3,921,000  2,170,000  3,551,000  
Interest Expense -   -   -   -  
Income Before Tax5,161,000  3,921,000  2,170,000  3,551,000  
Income Tax Expense1,731,000  1,160,000  680,000  77,000  
Minority Interest(39,000)(15,000)(6,000)(6,000)
Net Income From Continuing Ops3,430,000  2,761,000  1,490,000  3,474,000  
Non-recurring Events
Discontinued Operations10,704,000  4,000  4,831,000  (260,000)
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 14,095,000   2,750,000   6,315,000   3,208,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 14,095,000   2,750,000   6,315,000   3,208,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.